United Orthopedic (4129) — Capital Reinvestment Ratio
Latest as of December 2025:
1.13x
United Orthopedic (4129) has a Capital Reinvestment Ratio of 1.13x as of December 2025, meaning it reinvests 1% of its operating cash flow (NT$223.65 Million) in capital expenditures (NT$252.00 Million). See 4129 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.13x
Capex / Operating Cash Flow
Operating Cash Flow
NT$223.65 Million
TWD
Capital Expenditures
NT$252.00 Million
TWD
Data as of
Dec 2025
Most recent filing
United Orthopedic Capital Reinvestment Ratio (2015–2025)
This chart tracks United Orthopedic's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for United Orthopedic (2015–2025)
Year-by-year Capital Reinvestment Ratio for United Orthopedic from 2015 to 2025. For live market cap and broader valuation context, see 4129 market cap.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | NT$1.03 Billion | NT$761.23 Million | ▼ -9.7% |
| 2024 | 0.82x | NT$717.29 Million | NT$589.33 Million | ▼ -41.3% |
| 2023 | 1.40x | NT$398.43 Million | NT$557.53 Million | ▲ +23.5% |
| 2022 | 1.13x | NT$340.79 Million | NT$386.21 Million | ▲ +66.9% |
| 2021 | 0.68x | NT$334.64 Million | NT$227.21 Million | ▲ +41.1% |
| 2020 | 0.48x | NT$481.65 Million | NT$231.79 Million | ▼ -20.8% |
| 2019 | 0.61x | NT$492.45 Million | NT$299.41 Million | ▼ -98.0% |
| 2018 | 31.12x | NT$12.41 Million | NT$386.17 Million | ▼ -84.6% |
| 2017 | 201.60x | NT$2.90 Million | NT$584.43 Million | ▲ +9048.2% |
| 2016 | 2.20x | NT$179.03 Million | NT$394.53 Million | ▲ +167.9% |
| 2015 | 0.82x | NT$252.75 Million | NT$207.93 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow